BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9375926)

  • 1. DiGeorge anomaly and chromosome 10p deletions: one or two loci?
    Dasouki M; Jurecic V; Phillips JA; Whitlock JA; Baldini A
    Am J Med Genet; 1997 Nov; 73(1):72-5. PubMed ID: 9375926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2).
    Schuffenhauer S; Lichtner P; Peykar-Derakhshandeh P; Murken J; Haas OA; Back E; Wolff G; Zabel B; Barisic I; Rauch A; Borochowitz Z; Dallapiccola B; Ross M; Meitinger T
    Eur J Hum Genet; 1998; 6(3):213-25. PubMed ID: 9781025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DiGeorge syndrome and partial monosomy 10p: case report and review.
    Schuffenhauer S; Seidel H; Oechsler H; Belohradsky B; Bernsau U; Murken J; Meitinger T
    Ann Genet; 1995; 38(3):162-7. PubMed ID: 8540688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.
    Lindsay EA; Halford S; Wadey R; Scambler PJ; Baldini A
    Genomics; 1993 Aug; 17(2):403-7. PubMed ID: 8406492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. A review.
    Demczuk S; Aurias A
    Ann Genet; 1995; 38(2):59-76. PubMed ID: 7486827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome.
    Yatsenko SA; Yatsenko AN; Szigeti K; Craigen WJ; Stankiewicz P; Cheung SW; Lupski JR
    Clin Genet; 2004 Aug; 66(2):128-36. PubMed ID: 15253763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DiGeorge anomaly associated with 10p deletion.
    Monaco G; Pignata C; Rossi E; Mascellaro O; Cocozza S; Ciccimarra F
    Am J Med Genet; 1991 May; 39(2):215-6. PubMed ID: 2063928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
    McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
    Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
    Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
    Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digeorge anomaly associated with partial deletion of chromosome 22. Report of a case with X/22 translocation and review of the literature.
    Dallapiccola B; Marino B; Giannotti A; Valorani G
    Ann Genet; 1989; 32(2):92-6. PubMed ID: 2667458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14.
    Lichtner P; König R; Hasegawa T; Van Esch H; Meitinger T; Schuffenhauer S
    J Med Genet; 2000 Jan; 37(1):33-7. PubMed ID: 10633131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocalcemia impacts heart failure control in DiGeorge 2 syndrome.
    Chao PH; Chao MC; Hwang KP; Chung MY
    Acta Paediatr; 2009 Jan; 98(1):195-8. PubMed ID: 18795911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 10p deletion in a patient with hypoparathyroidism, severe mental retardation, autism and basal ganglia calcifications.
    Verri A; Maraschio P; Devriendt K; Uggetti C; Spadoni E; Haeusler E; Federico A
    Ann Genet; 2004; 47(3):281-7. PubMed ID: 15337474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular studies of DiGeorge syndrome.
    Fibison WJ; Budarf M; McDermid H; Greenberg F; Emanuel BS
    Am J Hum Genet; 1990 May; 46(5):888-95. PubMed ID: 2339689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome.
    Carey AH; Kelly D; Halford S; Wadey R; Wilson D; Goodship J; Burn J; Paul T; Sharkey A; Dumanski J
    Am J Hum Genet; 1992 Nov; 51(5):964-70. PubMed ID: 1415265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo-cardio-facial/DiGeorge syndrome on chromosome 22q11.
    Funke B; Pandita RK; Morrow BE
    Genomics; 2001 May; 73(3):264-71. PubMed ID: 11350118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic characterization of a 10p14 deletion that includes the DGS2 region in a patient with multiple anomalies.
    Skrypnyk C; Goecke TO; Majewski F; Bartsch O
    Am J Med Genet; 2002 Nov; 113(2):207-12. PubMed ID: 12407714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.